Results of a real-world study that included people with hemophilia from 33 countries show that people with hemophilia B, ...

Therini Bio anticipates using the proceeds to fund Phase 1b trials evaluating its lead candidate, THN391, for the treatment of Alzheimer’s Disease (AD) and Diabetic Macular Edema (DME), as well as ...